SNOA
Sonoma Pharmaceuticals, Inc.
Company overview
- Market capitalization
- $6.03M
- Employees
- 10
- Latest publication
- 2026-09-29
About Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and Pediacyn, an atopic dermatitis hydrogel. The company also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irrigation; Microdacyn60 oral care solution to treat mouth and throat infections; and Podiacyn, a foot care product. In addition, it offers MicrocynAH, an HOCl-based solution used to relieve common symptoms of hot spots, scratches, skin rashes, post-surgical sites, and irritated animal skin; MicrocynVS, an animal care product; Nanocyn, a hospital-grade disinfectant; Acuicyn, a solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns, a disinfectant; and Endocyn, a root canal irrigation solution. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado.
Financial statements
Income Quarterly
| Metric | Q4 20262026-03-31 · USD | Q3 20262025-12-31 · USD | Q2 20262025-09-30 · USD | Q4 20252025-03-31 · USD | Q2 20252024-09-30 · USD | Q3 20242023-12-31 · USD | Q2 20232022-09-30 · USD | Q1 20232022-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,561,000USD | 4,349,000USD | 5,604,000USD | 3,754,000USD | 3,579,000USD | 3,138,000USD | 3,331,000USD | 3,983,000USD |
| Cost Of Revenue | 3,380,000USD | 2,699,000USD | 3,484,000USD | 2,226,000USD | 2,218,000USD | 1,678,000USD | 1,795,000USD | 2,337,000USD |
| Gross Profit | 2,181,000USD | 1,650,000USD | 2,120,000USD | 1,528,000USD | 1,361,000USD | 1,460,000USD | 1,536,000USD | 1,646,000USD |
| Research Development | 545,000USD | 557,000USD | 575,000USD | 411,000USD | 506,000USD | 601,000USD | 200,000USD | 206,000USD |
| Selling General Administrative | 1,987,000USD | 1,771,000USD | 1,882,000USD | 1,773,000USD | 1,705,000USD | 1,703,000USD | 2,067,000USD | 3,066,000USD |
| Total Operating Expenses | 2,532,000USD | 2,328,000USD | 2,457,000USD | 2,184,000USD | 2,211,000USD | 2,304,000USD | 2,267,000USD | 2,501,000USD |
| Operating Income | -351,000USD | -678,000USD | -337,000USD | -656,000USD | -850,000USD | -844,000USD | -731,000USD | -855,000USD |
| Income Before Tax | -497,000USD | -949,000USD | -731,000USD | -528,000USD | -463,000USD | -923,000USD | -917,000USD | -922,000USD |
| Income Tax Expense | 84,000USD | -130,000USD | -197,000USD | 248,000USD | 147,000USD | -57,000USD | 100,000USD | -35,000USD |
| Tax Provision | 84,000USD | -130,000USD | -197,000USD | 248,000USD | 147,000USD | -57,000USD | 100,000USD | -35,000USD |
| Net Income | -581,000USD | -819,000USD | -534,000USD | -776,000USD | -610,000USD | -866,000USD | -1,017,000USD | -887,000USD |
| Net Income From Continuing Ops | -581,000USD | -819,000USD | -534,000USD | -776,000USD | -610,000USD | -866,000USD | -1,017,000USD | -887,000USD |
| Ebit | -351,000USD | -678,000USD | -337,000USD | -656,000USD | -850,000USD | -923,000USD | -917,000USD | -922,000USD |
| Ebitda | -318,000USD | -644,000USD | -301,000USD | -625,000USD | -815,000USD | -878,000USD | -889,000USD | -891,000USD |
| Depreciation And Amortization | 33,000USD | 34,000USD | 36,000USD | 31,000USD | 35,000USD | 45,000USD | 28,000USD | 31,000USD |
| Reconciled Depreciation | 33,000USD | 34,000USD | 36,000USD | 31,000USD | 35,000USD | 45,000USD | 28,000USD | 31,000USD |
| Total Other Income Expense Net | -146,000USD | -271,000USD | -394,000USD | 128,000USD | 387,000USD | -79,000USD | -186,000USD | -67,000USD |
| Interest Expense | — | — | — | — | — | — | 3,000USD | 9,000USD |
| Net Interest Income | — | — | — | — | — | — | 3,000USD | 0USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | -1,017,000USD | -887,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 86,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20042004-03-31 · USD | FY 20022002-03-31 · USD |
|---|---|---|
| Total Revenue | 902,000USD | 2,000,000USD |
| Gross Profit | 902,000USD | 1,185,000USD |
| Other Operating Expenses | 902,000USD | — |
| Total Operating Expenses | 902,000USD | 1,332,000USD |
| Operating Income | 902,000USD | -147,000USD |
| Interest Expense | 0USD | 0USD |
| Income Tax Expense | 8,040,000USD | 24,000USD |
| Net Income | -7,298,000USD | -167,000USD |
| Ebit | 902,000USD | -147,000USD |
| Ebitda | 1,062,000USD | -147,000USD |
| Depreciation And Amortization | 160,000USD | -4,000USD |
| Total Other Income Expense Net | -902,000USD | 147,000USD |
| Cost Of Revenue | — | 815,000USD |
| Research Development | — | 6,000USD |
| Selling General Administrative | — | 1,326,000USD |
| Income Before Tax | — | -143,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20272026-06-30 · USD | Q4 20262026-03-31 · USD | Q3 20262025-12-31 · USD | Q2 20262025-09-30 · USD | Q1 20262025-06-30 · USD | Q4 20252025-03-31 · USD | Q3 20252024-12-31 · USD | Q2 20252024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 18,107,000USD | 13,960,000USD | 13,623,000USD | 13,856,000USD | 14,594,000USD | 13,693,000USD | 13,668,000USD | 13,685,000USD |
| Cash And Equivalents | 5,338,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 16,268,000USD | 12,100,000USD | 12,145,000USD | 12,501,000USD | 13,107,000USD | 12,648,000USD | 12,380,000USD | 12,221,000USD |
| Other Current Assets | 3,962,000USD | 615,000USD | 3,499,000USD | 3,129,000USD | 3,098,000USD | 596,000USD | 1,596,000USD | 2,149,000USD |
| Other Non Current Assets | 66,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 11,513,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 5,447,000USD | 4,832,000USD | 4,217,000USD | 4,322,000USD | 4,848,000USD | 4,096,000USD | 3,703,000USD | 3,309,000USD |
| Total Stockholder Equity | 6,594,000USD | 3,095,000USD | 3,432,000USD | 3,787,000USD | 4,056,000USD | 4,411,000USD | 4,870,000USD | 5,352,000USD |
| Total Equity Including Noncontrolling Interest | 6,594,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 282,000USD | — | — | — | — | — | — | — |
| Net Receivables | 3,182,000USD | 5,435,000USD | 2,382,000USD | 2,703,000USD | 2,602,000USD | 3,763,000USD | 2,405,000USD | 3,157,000USD |
| Inventory | 3,786,000USD | 3,651,000USD | 3,703,000USD | 3,634,000USD | 3,802,000USD | 2,915,000USD | 3,143,000USD | 2,837,000USD |
| Property Plant Equipment Net | 868,000USD | 912,000USD | 956,000USD | 763,000USD | 837,000USD | 309,000USD | 334,000USD | 417,000USD |
| Accounts Payable | 2,191,000USD | 1,923,000USD | 1,646,000USD | 1,404,000USD | 2,046,000USD | 953,000USD | 1,395,000USD | 770,000USD |
| Short Term Debt | 160,000USD | 373,000USD | 146,000USD | 144,000USD | 235,000USD | 278,000USD | 90,000USD | 198,000USD |
| Common Stock | 0USD | — | — | — | — | — | — | — |
| Retained Earnings | -201,311,000USD | -200,981,000USD | -200,400,000USD | -199,581,000USD | -199,047,000USD | -197,806,000USD | -197,030,000USD | -196,102,000USD |
| Accumulated Other Comprehensive Income | -3,008,000USD | -3,242,999USD | -3,191,000USD | -3,365,000USD | -3,569,999USD | -4,375,999USD | -4,554,000USD | -4,197,000USD |
| Total Liab | — | 10,865,000USD | 10,191,000USD | 10,069,000USD | 10,538,000USD | 9,282,000USD | 8,798,000USD | 8,333,000USD |
| Other Current Liab | — | -3,312,000USD | -3,354,000USD | -3,332,000USD | -3,410,000USD | 2,224,000USD | -3,120,000USD | -2,911,000USD |
| Capital Stock | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cash | — | 2,399,000USD | 2,561,000USD | 3,035,000USD | 3,605,000USD | 5,374,000USD | 5,236,000USD | 4,078,000USD |
| Cash And Short Term Investments | — | 2,399,000USD | 2,561,000USD | 3,035,000USD | 3,605,000USD | 5,374,000USD | 5,236,000USD | 4,078,000USD |
| Current Deferred Revenue | — | 284,000USD | 314,000USD | 750,000USD | 731,000USD | 641,000USD | 302,000USD | 319,000USD |
| Net Debt | — | -1,557,000USD | -1,906,000USD | -2,500,000USD | -2,930,000USD | -5,069,000USD | -5,117,000USD | -3,834,000USD |
| Short Long Term Debt | — | 222,000USD | — | 56,000USD | 139,000USD | 220,000USD | — | 82,000USD |
| Short Long Term Debt Total | — | 842,000USD | 655,000USD | 535,000USD | 675,000USD | 305,000USD | 119,000USD | 244,000USD |
| Property Plant Equipment Gross | — | 3,392,000USD | 956,000USD | 763,000USD | 837,000USD | 2,384,000USD | 334,000USD | 417,000USD |
| Common Stock Shares Outstanding | — | 1,764,331shares | 1,713,000shares | 1,646,000shares | 1,641,000shares | 1,241,000shares | 1,464,000shares | 1,034,000shares |
| Non Current Assets Total | — | 1,860,000USD | 1,478,000USD | 1,355,000USD | 1,487,000USD | 1,045,000USD | 1,288,000USD | 1,464,000USD |
| Non Current Liabilities Total | — | 6,033,000USD | 5,974,000USD | 5,747,000USD | 5,690,000USD | 5,186,000USD | 5,095,000USD | 5,024,000USD |
| Non Currrent Assets Other | — | 64,000USD | 64,000USD | 84,000USD | 104,000USD | 147,000USD | 194,000USD | 255,000USD |
| Net Working Capital | — | 7,268,000USD | 7,928,000USD | 8,179,000USD | 8,259,000USD | 8,552,000USD | 8,677,000USD | 8,912,000USD |
| Unclassified Current Liabilities | — | 2,030,000USD | 2,111,000USD | 1,968,000USD | 1,697,000USD | — | 1,916,000USD | 1,940,000USD |
| Unclassified Non Current Liabilities | — | 6,033,000USD | 5,974,000USD | 5,747,000USD | 5,690,000USD | 5,186,000USD | 5,095,000USD | 5,024,000USD |
| Unclassified Equity | — | 207,318,999USD | 207,023,000USD | 206,733,000USD | 206,672,999USD | 206,592,999USD | 206,454,000USD | 205,651,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20262026-03-31 · USD | FY 20252025-03-31 · USD | FY 20242024-03-31 · USD | FY 20232023-03-31 · USD | FY 20222022-03-31 · USD | FY 20212021-03-31 · USD | FY 20202020-03-31 · USD | FY 20192019-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 13,960,000USD | 13,693,000USD | 14,740,000USD | 16,231,000USD | 18,845,000USD | 14,987,000USD | 14,561,000USD | 14,448,000USD |
| Other Current Assets | 615,000USD | 596,000USD | 707,000USD | 4,548,000USD | 3,964,000USD | 3,427,000USD | 2,527,000USD | 1,917,000USD |
| Total Liab | 10,865,000USD | 9,282,000USD | 8,603,000USD | 8,254,000USD | 10,148,000USD | 9,624,000USD | 8,937,000USD | 3,959,000USD |
| Total Stockholder Equity | 3,095,000USD | 4,411,000USD | 6,137,000USD | 7,977,000USD | 8,697,000USD | 5,363,000USD | 5,624,000USD | 10,489,000USD |
| Other Current Liab | -3,312,000USD | 2,224,000USD | -2,597,000USD | -2,206,000USD | -1,995,000USD | -2,324,000USD | 1,774,000USD | 1,771,000USD |
| Capital Stock | 0USD | 0USD | 2,000USD | 5,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD |
| Retained Earnings | -200,981,000USD | -197,806,000USD | -194,349,000USD | -189,514,000USD | -184,363,000USD | -179,277,000USD | -175,327,000USD | -169,238,000USD |
| Cash | 2,399,000USD | 5,374,000USD | 3,128,000USD | 3,820,000USD | 7,396,000USD | 4,220,000USD | 3,691,000USD | 3,689,000USD |
| Cash And Short Term Investments | 2,399,000USD | 5,374,000USD | 3,128,000USD | 3,820,000USD | 7,396,000USD | 4,220,000USD | 3,691,000USD | 3,689,000USD |
| Total Current Assets | 12,100,000USD | 12,648,000USD | 12,548,000USD | 13,798,000USD | 16,430,000USD | 12,983,000USD | 12,383,000USD | 12,496,000USD |
| Total Current Liabilities | 4,832,000USD | 4,096,000USD | 3,719,000USD | 3,717,000USD | 5,819,000USD | 4,078,000USD | 4,729,000USD | 3,591,000USD |
| Current Deferred Revenue | 284,000USD | 641,000USD | 478,000USD | 160,000USD | 1,277,000USD | 319,000USD | 273,000USD | 102,000USD |
| Net Debt | -1,557,000USD | -5,069,000USD | -2,520,000USD | -2,971,000USD | -6,029,000USD | -1,545,000USD | -2,841,000USD | -3,214,000USD |
| Short Term Debt | 373,000USD | 278,000USD | 521,000USD | 687,000USD | 1,058,000USD | 836,000USD | 615,000USD | 463,000USD |
| Short Long Term Debt | 222,000USD | 220,000USD | 323,000USD | 431,000USD | 808,000USD | 596,000USD | 481,000USD | 322,000USD |
| Short Long Term Debt Total | 842,000USD | 305,000USD | 608,000USD | 849,000USD | 1,367,000USD | 2,675,000USD | 850,000USD | 475,000USD |
| Net Receivables | 5,435,000USD | 3,763,000USD | 5,994,000USD | 2,572,000USD | 2,407,000USD | 2,806,000USD | 3,973,000USD | 3,481,000USD |
| Inventory | 3,651,000USD | 2,915,000USD | 2,719,000USD | 2,858,000USD | 2,663,000USD | 2,530,000USD | 2,192,000USD | 3,409,000USD |
| Accounts Payable | 1,923,000USD | 953,000USD | 607,000USD | 841,000USD | 1,641,000USD | 1,769,000USD | 2,067,000USD | 1,255,000USD |
| Property Plant Equipment Net | 912,000USD | 309,000USD | 651,000USD | 906,000USD | 879,000USD | 1,129,000USD | 1,328,000USD | 727,000USD |
| Property Plant Equipment Gross | 3,392,000USD | 2,384,000USD | 3,031,000USD | 2,920,000USD | 2,590,000USD | 1,129,000USD | 1,328,000USD | 727,000USD |
| Accumulated Other Comprehensive Income | -3,242,999USD | -4,375,999USD | -2,723,000USD | -3,418,000USD | -4,312,000USD | -4,579,000USD | -5,610,000USD | -4,349,000USD |
| Common Stock Shares Outstanding | 1,684,000shares | 1,241,000shares | 909,000shares | 339,400shares | 265,300shares | 199,600shares | 147,700shares | 92,398shares |
| Non Current Assets Total | 1,860,000USD | 1,045,000USD | 2,192,000USD | 2,433,000USD | 2,415,000USD | 2,004,000USD | 2,178,000USD | 1,952,000USD |
| Non Current Liabilities Total | 6,033,000USD | 5,186,000USD | 4,884,000USD | 4,537,000USD | 4,329,000USD | 5,546,000USD | 4,208,000USD | 368,000USD |
| Non Currrent Assets Other | 64,000USD | 147,000USD | 396,000USD | 578,000USD | 707,000USD | 875,000USD | 850,000USD | 1,225,000USD |
| Net Working Capital | 7,268,000USD | 8,552,000USD | 8,829,000USD | 10,081,000USD | 10,611,000USD | 8,905,000USD | 7,518,000USD | 8,905,000USD |
| Unclassified Current Liabilities | 2,030,000USD | — | 1,790,000USD | 1,598,000USD | 1,035,000USD | — | — | — |
| Unclassified Non Current Liabilities | 6,033,000USD | 5,186,000USD | 4,884,000USD | — | — | -3,707,000USD | 2,972,000USD | — |
| Unclassified Equity | 207,318,999USD | 206,592,999USD | 203,205,000USD | 200,899,000USD | 197,368,000USD | 189,215,000USD | 186,557,000USD | 184,072,000USD |
| Common Stock | — | — | 2,000USD | 5,000USD | 2,000USD | 2,000USD | 2,000USD | 2,000USD |
| Unclassified Non Current Assets | — | — | 1,145,000USD | — | — | — | — | -1,225,000USD |
| Other Liab | — | — | — | 4,375,000USD | 4,020,000USD | 3,707,000USD | 245,000USD | 356,000USD |
| Other Assets | — | — | — | 1,527,000USD | 1,536,000USD | 875,000USD | 850,000USD | 1,225,000USD |
| Net Tangible Assets | — | — | — | 7,977,000USD | 8,697,000USD | 5,363,000USD | 8,705,000USD | 10,489,000USD |
| Deferred Long Term Liab | — | — | — | — | — | 229,000USD | 245,000USD | 356,000USD |
| Long Term Debt | — | — | — | — | — | 1,310,000USD | — | 12,000USD |
| Non Current Liabilities Other | — | — | — | — | — | 4,007,000USD | 746,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20272026-06-30 · USD | Q4 20262026-03-31 · USD | Q3 20262025-12-31 · USD | Q2 20262025-09-30 · USD | Q1 20262025-06-30 · USD | Q4 20252025-03-31 · USD | Q3 20252024-12-31 · USD | Q2 20252024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -330,000USD | -581,000USD | -577,000USD | -776,000USD | -1,241,000USD | -928,000USD | -610,000USD | -610,000USD |
| Depreciation | 32,000USD | 33,000USD | 39,000USD | 31,000USD | 36,000USD | 33,000USD | 35,000USD | 35,000USD |
| Stock Based Compensation | 58,000USD | 135,000USD | -27,000USD | 90,000USD | 57,000USD | 13,000USD | 14,000USD | 14,000USD |
| Unclassified Operating Cash Flow | 282,000USD | — | — | — | — | — | — | — |
| Change To Account Receivables | -650,000USD | -168,000USD | 340,000USD | 215,000USD | -216,000USD | 646,000USD | 43,000USD | 43,000USD |
| Change To Inventory | -81,000USD | 19,000USD | -40,000USD | 291,000USD | -652,000USD | -309,000USD | -256,000USD | -256,000USD |
| Change In Working Capital | -691,000USD | 840,000USD | 99,000USD | 198,000USD | -512,000USD | 1,466,000USD | 904,000USD | 904,000USD |
| Operating Cash Flow | -649,000USD | — | — | — | — | — | — | — |
| Capital Expenditures | -2,000USD | -29,000USD | -47,000USD | -47,000USD | -106,000USD | -2,000USD | -26,000USD | -26,000USD |
| Investing Cash Flow | -2,000USD | — | — | — | — | — | — | — |
| Financing Cash Flow | 3,454,000USD | — | — | — | — | — | — | — |
| Effect Of Forex Changes On Cash | 136,000USD | — | — | — | — | — | — | — |
| Change In Cash | 2,939,000USD | -162,000USD | -474,000USD | 138,000USD | -1,769,000USD | 1,158,000USD | 1,489,000USD | 1,489,000USD |
| End Cash Flow | 5,338,000USD | — | — | — | — | — | — | — |
| Other Non Cash Items | — | -515,000USD | -217,000USD | 174,000USD | -448,000USD | 174,000USD | -55,000USD | -55,000USD |
| Total Cash From Operating Activities | — | -519,000USD | -764,000USD | -95,000USD | -2,015,000USD | 565,000USD | 354,000USD | 354,000USD |
| Free Cash Flow | — | -548,000USD | -811,000USD | -142,000USD | -2,121,000USD | 563,000USD | 328,000USD | 328,000USD |
| Total Cashflows From Investing Activities | — | -29,000USD | -47,000USD | -47,000USD | -106,000USD | -2,000USD | -26,000USD | -26,000USD |
| Net Borrowings | — | -51,000USD | -56,000USD | -83,000USD | -81,000USD | -81,000USD | -82,000USD | -122,000USD |
| Total Cash From Financing Activities | — | 387,000USD | 210,000USD | 242,000USD | -58,000USD | 708,000USD | 1,444,000USD | 1,444,000USD |
| Sale Purchase Of Stock | — | 0USD | — | — | — | 0USD | — | — |
| Issuance Of Capital Stock | — | 161,000USD | 266,000USD | 0USD | 0USD | 0USD | 790,000USD | 1,541,000USD |
| Begin Period Cash Flow | — | 2,561,000USD | 3,035,000USD | 5,236,000USD | 5,374,000USD | 4,078,000USD | 2,589,000USD | 2,589,000USD |
| End Period Cash Flow | — | 2,399,000USD | 2,561,000USD | 5,374,000USD | 3,605,000USD | 5,236,000USD | 4,078,000USD | 4,078,000USD |
| Other Cashflows From Investing Activities | — | 37,000USD | -37,000USD | — | — | — | — | — |
| Other Cashflows From Financing Activities | — | 277,000USD | -94,000USD | 302,000USD | — | 1,000USD | 25,000USD | 25,000USD |
| Investments | — | — | — | -10,000USD | -106,000USD | -47,000USD | -2,000USD | -26,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20262026-03-31 · USD | FY 20252025-03-31 · USD | FY 20242024-03-31 · USD | FY 20232023-03-31 · USD | FY 20222022-03-31 · USD | FY 20212021-03-31 · USD | FY 20202020-03-31 · USD | FY 20192019-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -3,175,000USD | -3,457,000USD | -4,835,000USD | -5,151,000USD | -5,086,000USD | -3,950,000USD | -3,308,000USD | -11,798,000USD |
| Depreciation | 139,000USD | 138,000USD | 176,000USD | 125,000USD | 186,000USD | 227,000USD | 312,000USD | 453,000USD |
| Stock Based Compensation | 255,000USD | 224,000USD | 516,000USD | 669,000USD | 382,000USD | 371,000USD | 839,000USD | 1,635,000USD |
| Other Non Cash Items | -515,000USD | 174,000USD | 161,000USD | 106,000USD | -2,032,000USD | 4,000USD | -773,000USD | -741,000USD |
| Change To Account Receivables | -122,000USD | 434,000USD | -230,000USD | 62,000USD | 1,971,000USD | 2,608,000USD | -2,190,000USD | -1,164,000USD |
| Change To Inventory | -465,000USD | -388,000USD | 184,000USD | 44,000USD | -100,000USD | -65,000USD | 323,000USD | -779,000USD |
| Change In Working Capital | -406,000USD | 2,476,000USD | 1,693,000USD | -1,864,000USD | 3,131,000USD | 1,384,000USD | -1,661,000USD | -1,266,000USD |
| Total Cash From Operating Activities | -3,933,000USD | -88,000USD | -2,398,000USD | -6,152,000USD | -4,248,000USD | -3,378,000USD | -4,591,000USD | -11,717,000USD |
| Capital Expenditures | -192,000USD | -80,000USD | -17,000USD | -269,000USD | -137,000USD | -179,000USD | -206,000USD | -100,000USD |
| Free Cash Flow | -4,125,000USD | -168,000USD | -2,415,000USD | -6,421,000USD | -4,385,000USD | -3,557,000USD | -4,797,000USD | -11,817,000USD |
| Total Cashflows From Investing Activities | -192,000USD | -80,000USD | -2,000USD | -258,000USD | -99,000USD | 388,000USD | 3,644,000USD | -131,000USD |
| Net Borrowings | -271,000USD | -404,000USD | -481,000USD | -379,000USD | -374,000USD | 1,021,000USD | -347,000USD | -478,000USD |
| Total Cash From Financing Activities | 477,000USD | 3,030,000USD | 1,676,000USD | 2,489,000USD | 7,396,000USD | 3,308,000USD | 1,029,000USD | 5,492,000USD |
| Sale Purchase Of Stock | 0USD | -1,000USD | 0USD | — | — | 3,597,000USD | 1,376,000USD | 5,970,000USD |
| Issuance Of Capital Stock | 427,000USD | 3,079,000USD | 1,784,000USD | 2,868,000USD | 7,554,000USD | 6,892,000USD | 1,376,000USD | 5,970,000USD |
| Change In Cash | -2,975,000USD | 2,246,000USD | -692,000USD | -3,576,000USD | 3,176,000USD | 529,000USD | 2,000USD | -6,377,000USD |
| Begin Period Cash Flow | 5,374,000USD | 3,128,000USD | 3,820,000USD | 7,396,000USD | 4,220,000USD | 3,691,000USD | 3,689,000USD | 10,066,000USD |
| End Period Cash Flow | 2,399,000USD | 5,374,000USD | 3,128,000USD | 3,820,000USD | 7,396,000USD | 4,220,000USD | 3,691,000USD | 3,689,000USD |
| Other Cashflows From Financing Activities | 277,000USD | 356,000USD | 373,000USD | 515,000USD | 216,000USD | 388,000USD | 1,376,000USD | 270,000USD |
| Investments | — | -80,000USD | -2,000USD | -258,000USD | -99,000USD | 388,000USD | 3,644,000USD | -131,000USD |
| Unclassified Financing Cash Flow | — | 3,079,000USD | 1,784,000USD | — | — | -1,698,000USD | -1,376,000USD | — |
| Other Cashflows From Investing Activities | — | — | 15,000USD | 11,000USD | 38,000USD | 567,000USD | 1,150,000USD | -31,000USD |
| Change To Liabilities | — | — | — | -2,160,000USD | 743,000USD | -811,000USD | 177,000USD | -32,000USD |
| Exchange Rate Changes | — | — | — | — | — | 211,000USD | -80,000USD | -21,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | 529,000USD | 2,000USD | -6,377,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | -1,414,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | Asia | 910,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | Europe | 1,964,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | Latin America | 626,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | Rest of World | 480,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | United States | 2,426,000 | USD | Disclosure |
| Q4 2026Quarterly · 2026-03-31 | Geography | Asia | 381,000 | USD | Legacy provider |
| Q4 2026Quarterly · 2026-03-31 | Geography | Europe | 1,725,000 | USD | Legacy provider |
| Q4 2026Quarterly · 2026-03-31 | Geography | Latin America | 759,000 | USD | Legacy provider |
| Q4 2026Quarterly · 2026-03-31 | Geography | Rest of World | 694,000 | USD | Legacy provider |
| Q4 2026Quarterly · 2026-03-31 | Geography | United States | 2,002,000 | USD | Legacy provider |
| FY 2026Yearly · 2026-03-31 | Geography | Asia | 2,900,000 | USD | 0001683168-26-004871 |
| FY 2026Yearly · 2026-03-31 | Geography | Europe | 6,904,000 | USD | 0001683168-26-004871 |
| FY 2026Yearly · 2026-03-31 | Geography | Latin America | 2,373,000 | USD | 0001683168-26-004871 |
| FY 2026Yearly · 2026-03-31 | Geography | Rest of World | 1,678,000 | USD | 0001683168-26-004871 |
| FY 2026Yearly · 2026-03-31 | Geography | United States | 5,674,000 | USD | 0001683168-26-004871 |
| Q3 2026Quarterly · 2025-12-31 | Geography | Asia | 800,000 | USD | 0001683168-26-000889 |
| Q3 2026Quarterly · 2025-12-31 | Geography | Europe | 1,560,000 | USD | 0001683168-26-000889 |
| Q3 2026Quarterly · 2025-12-31 | Geography | Latin America | 518,000 | USD | 0001683168-26-000889 |
| Q3 2026Quarterly · 2025-12-31 | Geography | Rest of World | 253,000 | USD | 0001683168-26-000889 |
| Q3 2026Quarterly · 2025-12-31 | Geography | United States | 1,218,000 | USD | 0001683168-26-000889 |
| Q1 2026Quarterly · 2025-06-30 | Geography | Asia | 662,000 | USD | 0001683168-25-005753 |
| Q1 2026Quarterly · 2025-06-30 | Geography | Europe | 1,468,000 | USD | 0001683168-25-005753 |
| Q1 2026Quarterly · 2025-06-30 | Geography | Latin America | 564,000 | USD | 0001683168-25-005753 |
| Q1 2026Quarterly · 2025-06-30 | Geography | Rest of World | 316,000 | USD | 0001683168-25-005753 |
| Q1 2026Quarterly · 2025-06-30 | Geography | United States | 1,005,000 | USD | 0001683168-25-005753 |
| Q4 2025Quarterly · 2025-03-31 | Geography | Asia | 485,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-03-31 | Geography | Europe | 1,472,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-03-31 | Geography | Latin America | 788,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-03-31 | Geography | Rest of World | 329,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-03-31 | Geography | United States | 680,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-03-31 | Geography | Asia | 2,317,000 | USD | 0001683168-26-004871 |
| FY 2025Yearly · 2025-03-31 | Geography | Europe | 5,523,000 | USD | 0001683168-26-004871 |
| FY 2025Yearly · 2025-03-31 | Geography | Latin America | 2,962,000 | USD | 0001683168-26-004871 |
| FY 2025Yearly · 2025-03-31 | Geography | Rest of World | 875,000 | USD | 0001683168-26-004871 |
| FY 2025Yearly · 2025-03-31 | Geography | United States | 2,611,000 | USD | 0001683168-26-004871 |
| FY 2025Yearly · 2025-03-31 | Product | Other | 538,000 | USD | 0001683168-25-004546 |
| FY 2025Yearly · 2025-03-31 | Product | Product | 13,732,000 | USD | 0001683168-25-004546 |
| FY 2025Yearly · 2025-03-31 | Product | Shipping And Handling | 18,000 | USD | 0001683168-25-004546 |
| Q3 2025Quarterly · 2024-12-31 | Geography | Asia | 579,000 | USD | 0001683168-26-000889 |
| Q3 2025Quarterly · 2024-12-31 | Geography | Europe | 1,257,000 | USD | 0001683168-26-000889 |
| Q3 2025Quarterly · 2024-12-31 | Geography | Latin America | 829,000 | USD | 0001683168-26-000889 |
| Q3 2025Quarterly · 2024-12-31 | Geography | Rest of World | 285,000 | USD | 0001683168-26-000889 |
| Q3 2025Quarterly · 2024-12-31 | Geography | United States | 614,000 | USD | 0001683168-26-000889 |
| Q2 2025Quarterly · 2024-09-30 | Geography | Asia | 776,000 | USD | 0001683168-25-007938 |
| Q2 2025Quarterly · 2024-09-30 | Geography | Europe | 1,506,000 | USD | 0001683168-25-007938 |
| Q2 2025Quarterly · 2024-09-30 | Geography | Latin America | 465,000 | USD | 0001683168-25-007938 |
| Q2 2025Quarterly · 2024-09-30 | Geography | Rest of World | 157,000 | USD | 0001683168-25-007938 |
| Q2 2025Quarterly · 2024-09-30 | Geography | United States | 675,000 | USD | 0001683168-25-007938 |
| Q1 2025Quarterly · 2024-06-30 | Geography | Asia | 477,000 | USD | 0001683168-25-005753 |
| Q1 2025Quarterly · 2024-06-30 | Geography | Europe | 1,288,000 | USD | 0001683168-25-005753 |
| Q1 2025Quarterly · 2024-06-30 | Geography | Latin America | 880,000 | USD | 0001683168-25-005753 |
| Q1 2025Quarterly · 2024-06-30 | Geography | Rest of World | 104,000 | USD | 0001683168-25-005753 |
| Q1 2025Quarterly · 2024-06-30 | Geography | United States | 642,000 | USD | 0001683168-25-005753 |
| FY 2024Yearly · 2024-03-31 | Geography | Asia | 2,298,000 | USD | 0001683168-25-004546 |
| FY 2024Yearly · 2024-03-31 | Geography | Europe | 4,781,000 | USD | 0001683168-25-004546 |
| FY 2024Yearly · 2024-03-31 | Geography | Latin America | 1,726,000 | USD | 0001683168-25-004546 |
| FY 2024Yearly · 2024-03-31 | Geography | Rest of World | 872,000 | USD | 0001683168-25-004546 |
| FY 2024Yearly · 2024-03-31 | Geography | United States | 3,058,000 | USD | 0001683168-25-004546 |
| FY 2024Yearly · 2024-03-31 | Product | Other | 394,000 | USD | 0001683168-25-004546 |
| FY 2024Yearly · 2024-03-31 | Product | Product | 12,313,000 | USD | 0001683168-25-004546 |
| FY 2024Yearly · 2024-03-31 | Product | Shipping And Handling | 28,000 | USD | 0001683168-25-004546 |
| Q1 2024Quarterly · 2023-06-30 | Product | Product | 3,328,000 | USD | 0001683168-23-005508 |
| Q1 2024Quarterly · 2023-06-30 | Product | Services | 99,000 | USD | 0001683168-23-005508 |
| FY 2023Yearly · 2023-03-31 | Geography | Asia | 2,451,000 | USD | 0001683168-24-004275 |
| FY 2023Yearly · 2023-03-31 | Geography | Europe | 4,051,000 | USD | 0001683168-24-004275 |
| FY 2023Yearly · 2023-03-31 | Geography | Latin America | 2,383,000 | USD | 0001683168-24-004275 |
| FY 2023Yearly · 2023-03-31 | Geography | Rest of World | 959,000 | USD | 0001683168-24-004275 |
| FY 2023Yearly · 2023-03-31 | Geography | United States | 3,428,000 | USD | 0001683168-24-004275 |
| FY 2023Yearly · 2023-03-31 | Product | Other | 1,304,000 | USD | 0001683168-24-004275 |
| FY 2023Yearly · 2023-03-31 | Product | Product | 11,926,000 | USD | 0001683168-24-004275 |
| FY 2023Yearly · 2023-03-31 | Product | Shipping And Handling | 42,000 | USD | 0001683168-24-004275 |
| Q1 2023Quarterly · 2022-06-30 | Product | Product | 2,955,000 | USD | 0001683168-23-005508 |
| Q1 2023Quarterly · 2022-06-30 | Product | Services | 1,028,000 | USD | 0001683168-23-005508 |
| FY 2022Yearly · 2022-03-31 | Product | Product | 12,179,000 | USD | 0001683168-23-004323 |
| FY 2022Yearly · 2022-03-31 | Product | Services | 449,000 | USD | 0001683168-23-004323 |
| FY 2022Yearly · 2022-03-31 | Product | Shipping And Handling | 52,000 | USD | 0001683168-23-004323 |
| FY 2021Yearly · 2021-03-31 | Product | Product | 18,517,000 | USD | 0001683168-22-004940 |
| FY 2021Yearly · 2021-03-31 | Product | Services | 112,000 | USD | 0001683168-22-004940 |
| FY 2021Yearly · 2021-03-31 | Product | Shipping And Handling | 37,000 | USD | 0001683168-22-004940 |
| Q3 2021Quarterly · 2020-12-31 | Product | Animal Care | 1,357,000 | USD | 0001683168-21-000580 |
| Q3 2021Quarterly · 2020-12-31 | Product | Human Skin Care | 3,534,000 | USD | 0001683168-21-000580 |
| Q3 2021Quarterly · 2020-12-31 | Product | Other Sales | 45,000 | USD | 0001683168-21-000580 |
| Q2 2021Quarterly · 2020-09-30 | Product | Animal Care | 951,000 | USD | 0001683168-20-004049 |
| Q2 2021Quarterly · 2020-09-30 | Product | Human Skin Care | 4,776,000 | USD | 0001683168-20-004049 |
| Q2 2021Quarterly · 2020-09-30 | Product | Other Sales | 42,000 | USD | 0001683168-20-004049 |
| Q1 2021Quarterly · 2020-06-30 | Product | Animal Care | 377,000 | USD | 0001683168-20-002761 |
| Q1 2021Quarterly · 2020-06-30 | Product | Human Skin Care | 6,864,000 | USD | 0001683168-20-002761 |
| Q1 2021Quarterly · 2020-06-30 | Product | Other Sales | 13,000 | USD | 0001683168-20-002761 |
| FY 2020Yearly · 2020-03-31 | Product | Product | 17,777,000 | USD | 0001683168-21-002977 |
| FY 2020Yearly · 2020-03-31 | Product | Services | 151,000 | USD | 0001683168-21-002977 |
| FY 2020Yearly · 2020-03-31 | Product | Shipping And Handling | 57,000 | USD | 0001683168-21-002977 |
| Q3 2020Quarterly · 2019-12-31 | Product | Animal Care | 853,000 | USD | 0001683168-21-000580 |
| Q3 2020Quarterly · 2019-12-31 | Product | Human Skin Care | 3,528,000 | USD | 0001683168-21-000580 |
| Q3 2020Quarterly · 2019-12-31 | Product | Other Sales | 14,000 | USD | 0001683168-21-000580 |
| Q2 2020Quarterly · 2019-09-30 | Product | Animal Care | 912,000 | USD | 0001683168-20-004049 |
| Q2 2020Quarterly · 2019-09-30 | Product | Human Skin Care | 3,801,000 | USD | 0001683168-20-004049 |
| Q2 2020Quarterly · 2019-09-30 | Product | Other Sales | 14,000 | USD | 0001683168-20-004049 |
| Q1 2020Quarterly · 2019-06-30 | Product | Animal Care | 423,000 | USD | 0001683168-20-002761 |
| Q1 2020Quarterly · 2019-06-30 | Product | Human Skin Care | 3,962,000 | USD | 0001683168-20-002761 |
| Q1 2020Quarterly · 2019-06-30 | Product | Other Sales | 0 | USD | 0001683168-20-002761 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.